ProMetic Life Sciences Inc. is publicly traded, global biopharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics, clinical diagnostics, and the elimination of pathogens, and is developing products to treat anemia, neutropenia, cancer, and autoimmune disease/inflammation.